Sanofi pivots toward boosters after Covid vaccine delays
Sanofi ends development of Covid Messenger-RNA vaccine.
By Marthe Fourcade, Bloomberg
(Bloomberg) --Sanofi will focus on supplying Covid-19 booster shots and fine-tuning its messenger RNA platform for the next pandemic after delays placed the drugmaker at least a year behind rivals in developing vaccines.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
